Search results
New Alzheimer’s treatment drug gets support from FDA advisory panel
WXYZ-TV Detroit· 21 minutes agoIf approved by the FDA, it would become the second Alzheimer’s drug on the market. Alzheimer’s is an incurable disease that affects nearly 7 million Americans today. An outside ...
Annexon’s neurological disease drug meets main goal of late-stage study
WSAU Wausau· 6 days ago(Reuters) -Annexon said on Tuesday its experimental drug to treat a rare neurological disease met the main goal of a late-stage trial, sending its shares ...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 16 hours agoA panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s ...
Two-Drug Treatment Could Curb Meth Addiction
US News & World Report· 11 hours agoThough overdose deaths continue to surge, there is no approved medication to treat methamphetamine use disorder. Now, an experimental two-drug therapy has ...
Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease | FOX 28 Spokane
FOX 28 Spokane· 11 hours agoAn experimental ‘supercharged’ form of popular GLP-1 weight-loss meds could help ease fatty liver...
The world's first drug that can regrow teeth has been approved for human trials this year
UNILAD· 6 days agoIn a significant breakthrough, the world's first drug that can regrow teeth has been approved for...
Annexon's neurological disease drug succeeds in late-stage study
Reuters via AOL· 6 days ago(Reuters) -Annexon said on Tuesday a late-stage study showed its experimental drug helped improve motor functions in patients with Guillain-Barre syndrome ...
Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease
US News & World Report· 11 hours agoAn experimental 'supercharged' form of popular GLP-1 weight-loss meds could help ease fatty liver disease, a new trial suggests. The drug under development ...
U.S. FDA places hold on Biomea’s diabetes trial
WSAU Wausau· 4 days ago(Reuters) - Biomea Fusion said on Thursday the U.S. Food and Drug Administration had placed a clinical hold on its ongoing early-to-mid stage study of...
Skye Bioscience to stop eye disease drug development after failing mid-stage study
WSAU Wausau· 10 hours ago(Reuters) -Skye Bioscience said on Monday it would discontinue development of its experimental eye disease treatment after the drug failed to meet the main ...